School of Psychology.
Health Psychol. 2023 Apr;42(4):247-256. doi: 10.1037/hea0001270. Epub 2023 Feb 27.
Severe or persistent distress is associated with poorer quality of life in cancer survivors. Distress follows distinct trajectories within different population subgroups. Identifying characteristics and causes of trajectories can assist intervention development and targeting. In a 7-year study of uveal melanoma survivors, we aimed to characterize anxiety, depression, and fear of cancer recurrence (FCR) trajectories, and identify whether concerns about symptoms and functional problems over the first 3 years of survivorship predict memberships of high distress trajectories.
In a closed cohort study, we used growth mixture modeling (GMM) to identify statistically optimal trajectories over 6-, 12-, 24-, 36-, 48-, 60-, 72-, and 84-month time point posttreatment in 475 patients. We then regressed trajectory memberships onto a 3-year series of measures of concerns about symptoms and functional problems, controlling demographic, clinical, and 6-month anxiety, depression, or FCR indicators.
Anxiety, depression, and FCR were represented by two-class linear GMMs. The majority scored consistently low, but 17.5% showed consistently elevated anxiety, 10.9% consistently elevated depression, and 19.4% consistently elevated FCR. Higher anxiety trajectory membership was predicted by greater concerns about symptoms at 6 and 24 months, higher depression trajectory membership by symptoms at 24 months, and higher FCR trajectory membership by symptoms at 6 and 24 months and functional problems at 12 months.
Much of the burden of persistent distress in cancer patients falls on a small proportion of survivors. Concerns about symptoms and functional problems are potential risk factors for distress. (PsycInfo Database Record (c) 2023 APA, all rights reserved).
严重或持续的困扰与癌症幸存者生活质量较差有关。在不同的人群亚组中,困扰会呈现出不同的轨迹。确定轨迹的特征和原因可以帮助制定干预措施并进行针对性治疗。在一项为期 7 年的葡萄膜黑色素瘤幸存者研究中,我们旨在描述焦虑、抑郁和对癌症复发的恐惧(FCR)轨迹,并确定在生存后的前 3 年中对症状和功能问题的担忧是否预示着高度困扰轨迹的成员身份。
在一项封闭队列研究中,我们使用增长混合建模(GMM)在 475 名患者中确定了治疗后 6、12、24、36、48、60、72 和 84 个月时间点的最佳轨迹。然后,我们将轨迹成员身份回归到 3 年一系列对症状和功能问题的担忧的测量值上,控制人口统计学、临床和 6 个月的焦虑、抑郁或 FCR 指标。
焦虑、抑郁和 FCR 由两个类别的线性 GMM 表示。大多数人的得分一直较低,但 17.5%的人表现出持续升高的焦虑,10.9%的人持续升高的抑郁,19.4%的人持续升高的 FCR。较高的焦虑轨迹成员身份由 6 个月和 24 个月时对症状的更大担忧预测,较高的抑郁轨迹成员身份由 24 个月时的症状预测,较高的 FCR 轨迹成员身份由 6 个月和 24 个月时的症状和 12 个月时的功能问题预测。
癌症患者持续困扰的大部分负担落在一小部分幸存者身上。对症状和功能问题的担忧是困扰的潜在危险因素。(PsycInfo 数据库记录(c)2023 APA,保留所有权利)。